Amyvid

(Florbetapir F 18)

Amyvid

Drug updated on 11/16/2023

Dosage FormInjection (intravenous; 500-1900 MBq/mL)
Drug ClassRadioactive diagnostic agents
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.

Product Monograph / Prescribing Information

Document TitleYearSource
Amyvid (Florbetapir F 18 Injection) Prescribing Information.2023Lilly USA LLC, Indianapolis, IN

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines